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Background: Primary umbilical melanoma is an uncommon tumor that is poorly described in the medical
literature. The umbilical region is a particular anatomic site owing to the presence of embryonal remnants, which
can be a potential metastatic pathway, as well as the braided lymphatic network drainage. Hence, primary
malignant neoplasms affecting the umbilicus require a different and more radical surgical approach compared with
other melanomas.
Case presentation: In this report, we describe a series of three patients of Caucasian ethnicity who presented with
primary umbilical melanoma at the National Cancer Institute of Naples, Italy. All patients underwent wide excision
of the tumor including the underlying peritoneum. No surgical complications, either immediate or delayed, were
observed in any of the patients. Sentinel lymph node biopsy was negative in two cases. Two of the patients
developed metastatic disease and died after systemic medical therapy. The other patient is currently in follow-up,
and remains disease-free after 21 months.
Conclusions: The umbilicus has vascular and embryological connections with the underlying peritoneum, so that
early visceral involvement is more likely to occur with primary umbilical melanomas. As such, tumor resection
including the underlying peritoneum is required to avoid local relapse, whilst sentinel lymph node biopsy appears
to be of poor diagnostic value.
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Primary umbilical melanoma is an uncommon disease,
with only 23 cases described in the medical literature since
it was first reported in 1916 [1] (Table 1). The umbilical
region represents an anatomic site with unique character-
istics, owing to the presence of embryonal remnants which
provide a potential metastatic pathway, as well as the
braided lymphatic drainage network. Hence, primary ma-
lignant neoplasms that affect the umbilicus require a dif-
ferent surgical approach compared with other melanomas
[2]. In this report, we describe three patients who pre-
sented with primary umbilical melanoma at the National* Correspondence: gidimonta@libero.it
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2010 and April 2011.Case presentation
Case 1
A 33-year-old Caucasian female presented with a coarse
nodular pinkish-brown swelling that covered the natural
umbilical cavity. Diagnosis of a nodular melanoma was
based on clinical findings, with histological investigation
showing a Breslow thickness of 40 mm, ulceration, mitotic
rate of 6/mm2 and no tumor-infiltrating lymphocytes
(Figure 1). Whole-body fluorodeoxyglucose positron emis-
sion tomography/computed tomography (FDG PET/CT)
was negative for distant disease. The patient underwent
pre-operative Tc99 lymphoscintigraphy according to stand-
ard procedure and subsequent removal of the umbilicalral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,




Cullen TS [5] 1916 3 Excision
Graev M [6] 1957 1 Excision
Hughes J [7] 1963 1 Excision
Steck WD [8] 1965 4 Excision
Breuninger H [9] 1996 7 Excision and plastic
reconstruction
Colonna MR [10] 1999 2 Excision and plastic
reconstruction
Meine JG [2] 2003 1 Excision and plastic
reconstruction
Campos-Muñoz [11] 2007 1 Excision, SLNB and
plastic reconstruction
Mangas C [12] 2008 1 Excision and plastic
reconstruction
Cecchi R [3] 2009 1 Excision and SLNB
Zaccagna A [1] 2011 1 Excision, SLNB and
plastic reconstruction
Current study 2014 3 Excision, SLNB and
plastic reconstruction
Total 26
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including the underlying peritoneum. Sentinel lymph node
biopsy (SLNB) in the left inguinal and bilateral axillary re-
gions, as indicated by lymphoscintigraphy, were negative
for metastases. Six months after surgery, there was local
recurrence involving the posterior aspect of the left rectus
muscle up to the peritoneum. The patient underwent sur-
gical removal of both rectus muscles including the local
recurrence (Figure 2), with the abdominal wall being re-
constructed with non-absorbable Marlex mesh.
However, the patient subsequently developed multiple
inoperable nodal and abdominal metastases. A BRAF
mutation test was positive and, because BRAF mutationFigure 1 Case 1. (a) Specimen cut in half: Umbilicus cavity is completely fi
disorganized and immature (hematoxylin and eosin, ×10) (c) diffused aniso
nucleoli (hematoxylin and eosin, ×60).is associated with enhanced and selective sensitivity to
MEK inhibition when compared to either wild-type cells
or cells with a RAS mutation, the patient was enrolled in
an experimental clinical protocol involving treatment
with a selective MEK inhibitor (MEK162 15 mg orally).
After four months, an 18FDG PET/CT scan showed a sig-
nificant response to treatment with minor intestinal
18FDG accumulation in peritoneal thickening close to the
bladder (maximum standardized uptake value [SUVmax] of
3.6), and the disappearance of lymphadenopathy and
swellings in the subcutaneous fat pad of the abdominal
wall. Therapy was continued for three months, until dis-
ease progression was observed on a total body CT scan.
Considering the BRAF mutation-positive status of the
patient, treatment was switched to oral vemurafenib
240 mg, a selective BRAF inhibitor. However, this was
stopped after 8 weeks due to clinical disease progression.
The patient then began a new line of therapy with
ipilimumab 3 mg/kg as part of an Italian expanded ac-
cess programme. Six months later the patient received
her fourth administration of ipilimumab, and was com-
pletely free of ascites and/or bowel symptoms. The patient
died 28 months after initial diagnosis of the disease.Case 2
A 50-year-old Caucasian female had previously undergone
removal of a pigmented lesion of the umbilical region at a
hospital other than our institute, with histological findings
of superficial spreading melanoma, Breslow thickness
2.5 mm, ulceration, mitotic rate of 6/mm2 and brisk
tumor-infiltrating lymphocytes. After referral to our
centre, the umbilical region, including the scar from the
initial excision of the lesion, with a 2 cm lateral margin in-
cluding the underlying peritoneum was surgically removed
(Figure 3). The reconstruction of the umbilicus was car-
ried out by means of two local transposition flaps trans-
ferred towards the linea alba. SLNB in the right inguinallled by tumor (b) poorly differentiated cells, that look primitive,
cytosis, anisonucleosis, altered nuclear-cytoplasmic ratio and evident
Figure 2 Case 1 local recurrence. (a) Local recurrence involving the left rectus muscle up to the peritoneum (b) removal of both rectus muscles
including the overlying skin bearing the scar of previous excision.
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disease-free after 21 months of follow-up.
Case 3
A 77-year-old Caucasian male had previously undergone
removal of a pigmented lesion in the umbilical region at
another hospital. Histology showed an ulcerated cutane-
ous melanoma of 3 mm thickness and mitotic rate of
6/mm2. No further treatment was administered until,
twelve months later, the patient presented with a swell-
ing underlying his umbilicus. Clinical and instrumental
examinations showed a coarse nodular swelling in the
umbilical region, most likely local disease recurrence,
and major lymphadenopathy of 54 × 28 mm in the left
groin, which was positive in pre-operative cytology. The
patient underwent left superficial and deep groin dissec-
tion and omphalectomy, with 2 cm of lateral margin ex-
tended up to the underlying peritoneum (Figure 4). TheFigure 3 Case 2. (a) Pre-operative view (b) wide excision comprising the upatient then underwent medical treatment of subsequent
bone and liver metastases but died eight months later
due to disseminated disease.Discussion
Melanoma of the umbilical region is a rare and particularly
aggressive neoplastic disease. Primary umbilical malignan-
cies are very poorly described, consisting of melanomas,
basal cell and squamous cell carcinomas. The umbilicus
has vascular and embryological connections with the
underlying peritoneum, with the urachus, vitelline artery
and round ligament of the liver representing the main
metastatic spread pathway. Primary umbilical melanoma
determines a possible early visceral involvement and so
should be approached with a wide excision of the entire
umbilical structure, including the attachment to the under-
lying peritoneum [3].nderlying peritoneum.
Figure 4 Case 3. (a) Computed tomography image showing nodular swelling in the umbilical region (b) Computed tomography image of left
groin lymphadenopathy of 54 x 28 mm (c) pre-operative view (d) wide excision comprising the underlying peritoneum.
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12 months after the second surgery. The second patient is
currently in follow-up, and remains disease-free after
21 months. In the third patient, bone and liver metastases
developed a year after the diagnosis of primary umbilical
melanoma and led to the patient’s death. No surgical com-
plications, either immediate or delayed, were observed in
any of the patients. The medical oncology staff treated two
of the three patients for systemic disease.
The difference between primary umbilical melanoma
and metastatic tumors of the umbilicus should be noted.
Metastatic tumors account for approximately 80-88% of
malignancies occurring in the umbilical area [3,4]. The
classic example is the “Sister Mary Joseph nodule,”
representing a metastasis from the gastrointestinal tract.
In a review of 77 umbilical malignancies at a single
centre, the most common primary sites with metastasis
to the umbilicus were the ovary, endometrium, andpancreatobiliary tree in women, and the genitourinary
tract, pancreatobiliary tree, and gastrointestinal tract in
men [2-4].
SLNB for primary umbilical melanomas are very rarely
reported. The umbilicus has a lymphatic drainage involving
axilla and inguinal areas or, more rarely, internal mammary,
iliac or intra-abdominal lymph nodes [1]. In our patients,
lymphoscintigraphy showed the presence of the sentinel
lymph node in both armpits and left groin in the first pa-
tient and in the right groin in the second patient. As such,
the potential role of SLNB of umbilical tumors represents
an unanswered question but at present has to be consid-
ered of poor diagnostic value.Conclusions
Primary umbilical melanoma should be considered a differ-
ent pathology from common cutaneous melanoma. Tumor
Di Monta et al. BMC Research Notes  (2015) 8:147 Page 5 of 5excision en bloc with the underlying peritoneum is required
to avoid local relapse. Immediate reconstruction of the
neo-umbilicus with local flaps should be carried out at the
same time, while respecting the aggressive nature of the
neoplasm. SLNB appears to be of poor diagnostic value.
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